Vivodyne's AI experiments on lab-grown human tissue could soon replace the need to test drugs on mice or dogs—and the approach has the potential to create drugs that work better.
The Sam Altman-led company said it cannot rule out that the Astra model has reached the “Critical” threshold, meaning it can ...